7498 Results (Page 28 of 300)
Pharmaceuticals Markets Research Reports
Japan Cold Pain Therapy Market Analysis
The Japan Cold Pain Therapy Market was valued at $137 Mn in 2022 and is predicted to grow at a CAGR of 5.7% from 2023 to 2030, to $213 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic pain disorders, growing consumer demand, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Mentholatum, Eisai, Lion, Ossur, Romsons, Pfizer, Hisamitsu, and Johnson & Johnson among others.
Canada Cold Pain Therapy Market Analysis
The Canada Cold Pain Therapy Market was valued at $176 Mn in 2022 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $264 Mn by 2030. The key drivers of this industry include the increasing prevalence of pain disorders, focus on non-pharmaceutical options, product innovation, and technological advances. The industry is primarily dominated by players such as Hisamitsu, Polar Products, Rapid Aid, Romsons, Pic Solution, and Unexo among others.
South Africa Chronic Pain Therapeutics Market Analysis
The South Africa Chronic Pain Therapeutics Market is anticipated to experience a growth from $483 Mn in 2022 to $838 Mn by 2030, with a CAGR of 7.13% during the forecast period of 2022-2030. The key drivers of the chronic pain therapeutics market include the increasing prevalence of chronic pain conditions, the continual progress in medical technology leading to innovative solutions, and heightened public awareness and education. The South Africa Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Merck, Johnson and Johnson, Teva, Cipla, Mankind Pharma, etc., among various others.
Malaysia Chronic Pain Therapeutics Market Analysis
The Malaysia Chronic Pain Therapeutics Market is anticipated to experience a growth from $119 Mn in 2022 to $192 Mn by 2030, with a CAGR of 6.1% during the forecast period of 2022-2030. Malaysia is witnessing market growth due to factors such as the growing awareness of chronic pain, supported by governmental initiatives aimed at improving access to treatment and the escalating burden of chronic pain. The Malaysia Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AstraZeneca, Sanofi, Merck, Roche, AbbVie, Novartis, Duopharma, Pharmaniaga, Healthex, etc., among various others.
Kenya Chronic Pain Therapeutics Market Analysis
The Kenya Chronic Pain Therapeutics Market is anticipated to experience a growth from $52 Mn in 2022 to $89 Mn by 2030, with a CAGR of 7% during the forecast period of 2022-2030. Kenya's market is driven by rising prevalence due to socioeconomic limitations, and the increasing advancements in medical technology, coupled with growing demand for affordable and accessible solutions. The Kenya Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AbbVie, Roche, Sanofi, Merck, Beta Healthcare, Cipla, Cosmos, Teva, Pharmaken, etc., among various others.
Germany Chronic Pain Therapeutics Market Analysis
The Germany Chronic Pain Therapeutics Market is anticipated to experience a growth from $2.719 Bn in 2022 to $3.750 Bn by 2030, with a CAGR of 4.1% during the forecast period of 2022-2030. The market growth is influenced by a mix of certain factors like the increasing elderly population with a higher prevalence of chronic pain conditions, continuous innovations in medical research and technology, and a rising awareness coupled with enhanced healthcare accessibility. The Germany Chronic Pain Therapeutics Market encompasses various players across different segments, including Sanofi, Pfizer, Merck, Novartis, Bayer, AstraZeneca, Boehringer Ingelheim, Weleda, Teva, Neuraxpharm, etc., among various others.
China Chronic Pain Therapeutics Market Analysis
The China Chronic Pain Therapeutics Market is anticipated to experience a growth from $5.973 Bn in 2022 to $10.573 Bn by 2030, with a CAGR of 7.4% during the forecast period of 2022-2030. The key drivers of the chronic pain management market in China are the increased prevalence of chronic conditions, the aging population and associated comorbidities, increasing healthcare awareness, and the rising demand for non-opioid pain management alternatives. The China Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Merck, Sanofi, AstraZeneca, Innovent Biologics, Shanghai Pharmaceuticals, Henlius Medical, BGI Genomics, Shanghai Fosun Pharma, etc., among various others.
South Korea Cardiovascular Drugs Market Analysis
South Korea Cardiovascular Drug Market is at around $2.02 Bn in 2022 and is projected to reach $2.94 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. The main elements propelling this industry's growth include the incidence of cardiovascular diseases, changing lifestyles, and government programs. The market is dominated by key players like Hanmi Pharmaceutical, Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffmann-La Roche Ltd.
South Korea Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the South Korea Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
Switzerland Infectious Disease Drugs Market Analysis
This report presents a strategic analysis of the Switzerland Infectious Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Switzerland Infectious Disease Drugs Market, offering unmatched value, accuracy, and expert insights.
UAE Lung Cancer Drugs Market Analysis
The UAE Lung Cancer Drug Market is projected to grow from $48 Mn in 2022 to $97 Mn by 2030, registering a CAGR of 9.3% during the forecast period of 2022 - 2030. According to the World Health Organization (WHO), lung cancer is the second most common cancer in both men and women in the UAE, accounting for 13% of all cancer cases. Some of the major local players in the UAE lung cancer drug market include Emirates Pharmaceutical Industries, Gulf Pharmaceutical Industries, and Julphar.
UK Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the UK Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
UK Women's Health Market Analysis
In the UK, the National Health Service (NHS) provides free medical care to women, as a result, the market size of UK women’s health is predicted to witness an upsurge of about $537 Mn in 2022 with a CAGR of 5.5% and is estimated to reach $824 Mn in 2030. Growing female labour force participation, particularly in the UK, has made a substantial contribution to the market's expansion. The market is segmented by product type and by disease type. Amgen, Allergen, and Merck and Co. are some of the leading players in the women’s health market.
Ukraine Infectious Disease Drugs Market Analysis
This report presents a strategic analysis of the Ukraine Infectious Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Ukraine Infectious Disease Drugs Market, offering unmatched value, accuracy and expert insights.
Ukraine Depression Therapeutics Market Analysis
This report presents a strategic analysis of the Ukraine Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Ukraine Depression Therapeutics Market, offering unmatched value, accuracy and expert insights.
APAC Infectious Disease Therapeutics Market Analysis
This report presents a strategic analysis of the APAC Infectious Disease Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC Infectious Disease Therapeutics Market, offering unmatched value, accuracy and expert insights.
APAC Antibacterial (Antibiotics) Drugs Market Analysis
This report presents a strategic analysis of the APAC Antibacterial (Antibiotics) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC Antibacterial (Antibiotics) Drugs Market, offering unmatched value, accuracy and expert insights.
APAC ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
This report presents a strategic analysis of the APAC ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market, offering unmatched value, accuracy and expert insights.
APAC Antiviral Drugs Market Analysis
This report presents a strategic analysis of the APAC Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC Antiviral Drugs Market, offering unmatched value, accuracy and expert insights.
APAC Cardiovascular Drugs Market Analysis
This report presents a strategic analysis of the APAC Cardiovascular Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC Cardiovascular Drugs Market, offering unmatched value, accuracy and expert insights.
Africa Antifungal Drugs Market Analysis
This report presents a strategic analysis of the Africa Antifungal Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Africa Antifungal Drugs Market, offering unmatched value, accuracy and expert insights.
Africa Rheumatology Drugs Market Analysis
This report presents a strategic analysis of the Africa Rheumatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Africa Rheumatology Drugs Market, offering unmatched value, accuracy and expert insights.
India Insulin Market Analysis
This report presents a strategic analysis of the India Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Insulin Market, offering unmatched value, accuracy and expert insights.
China Oral Care Market Analysis
China's oral care market was valued at $2.8 Bn in 2022 and is estimated to expand at a CAGR of 7.7% from 2022 to 2030 and will reach $5.1 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Hawley & Hazel, Yunnan Baiyao Group, Shanghai Jahwa United Co, Guangzhou Lion Company, Fujian Sanli Group, Midmark, iByer Dental Group, Bybo Dental Group, ChengDu Huamei Dental Chain Co, Sirona Dental Systems, and Foshan.
Africa Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the Africa Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Africa Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
